Trial intelligence / Profile preview

Crofelemer for Functional Diarrhea

NCT04486326Phase 4Terminated

Sponsor
Beth Israel Deaconess Medical Center
Start
Aug 2020
Primary completion
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of crofelemer in functional diarrhea, sponsored by Beth Israel Deaconess Medical Center. Started Aug 2020; status: terminated.

02

Drugs

crofelemer
03

Conditions

functional diarrhea

Beyond the preview

Go deeper on NCT04486326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04486326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call